KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Net Cash Flow (2016 - 2025)

Gilead Sciences' Net Cash Flow history spans 17 years, with the latest figure at $229.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 95.43% year-over-year to $229.0 million; the TTM value through Dec 2025 reached -$2.5 billion, down 163.84%, while the annual FY2025 figure was -$2.5 billion, 163.84% down from the prior year.
  • Net Cash Flow reached $229.0 million in Q4 2025 per GILD's latest filing, down from $2.2 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $5.0 billion in Q4 2024 to a low of -$2.9 billion in Q2 2025.
  • Average Net Cash Flow over 5 years is $77.8 million, with a median of $130.5 million recorded in 2022.
  • The largest YoY upside for Net Cash Flow was 31614.29% in 2024 against a maximum downside of 356.63% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $985.0 million in 2021, then plummeted by 35.23% to $638.0 million in 2022, then crashed by 46.24% to $343.0 million in 2023, then surged by 1360.64% to $5.0 billion in 2024, then plummeted by 95.43% to $229.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Net Cash Flow are $229.0 million (Q4 2025), $2.2 billion (Q3 2025), and -$2.9 billion (Q2 2025).